Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Tolerance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05590364
What this trial is testing

Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands

Who this might be right for
Skin LaxitySkin Roughness
IBSA Farmaceutici Italia Srl 51
Not applicableStudy completedNCT03279159
What this trial is testing

Hydrating Efficacy and Tolerance Evaluation of a Face Cream

Who this might be right for
Dry and Damaged Skin
Derming SRL 18
Early research (Phase 1)Study completedNCT04100642
What this trial is testing

A Phase I Clinical Study of Hemay808

Who this might be right for
Safety Issues
Tianjin Hemay Pharmaceutical Co., Ltd 42
Testing effectiveness (Phase 2)Study completedNCT00000435
What this trial is testing

DnaJ Peptide for Relieving Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 160
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Not applicableStudy completedNCT00367224
What this trial is testing

Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo

Who this might be right for
Vitiligo
Henry Ford Health System 17
Testing effectiveness (Phase 2)Study completedNCT02038218
What this trial is testing

Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors

Who this might be right for
Primary Brain TumorsMetastatic Malignant Neoplasm to Brain
DEKK-TEC, Inc. 29
Early research (Phase 1)Study completedNCT04452214
What this trial is testing

The Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungUrothelial CarcinomaMalignant Melanoma+1 more
Cantargia AB 19
Testing effectiveness (Phase 2)Study completedNCT00741338
What this trial is testing

Immune Tolerance Study With Aldurazyme® (Laronidase)

Who this might be right for
Mucopolysaccharidosis I
Genzyme, a Sanofi Company 7
Not applicableStudy completedNCT00818311
What this trial is testing

Skin Safety Profile of Different Exposure to the Light Emitting Diode (LED) in Healthy Subjects

Who this might be right for
Radiation ToleranceSkin AgingRhytids
L'Oreal 100
Not applicableUnknownNCT05691634
What this trial is testing

Prospective Study Evaluating the Clinical Tolerance of Skin Tattoos During MRI Examinations (TATOU - IRM)

Who this might be right for
Tattoo DisorderMRI
Elsan 3,000
Early research (Phase 1)WithdrawnNCT00001054
What this trial is testing

The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children

Who this might be right for
Herpes SimplexHIV InfectionsChickenpox
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT00001953
What this trial is testing

The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers

Who this might be right for
Sjogren's Syndrome
National Institute of Dental and Craniofacial Research (NIDCR) 32
Testing effectiveness (Phase 2)UnknownNCT05917561
What this trial is testing

Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo

Who this might be right for
Vitiligo
University Hospital, Bordeaux 48
Not applicableActive Not RecruitingNCT06746142
What this trial is testing

Dosimetric Comparison of Target Volume, Heart and Left Lung in Post Mastectomy Radiotherapy (RT) of Left Sided Breast Cancer by Free Breathing (FB) Versus Deep Inspiration Breath Hold (DIBH) Technique

Who this might be right for
Carcinoma BreastRadiation Therapy for Primary Breast CancerRadiation Tolerance+4 more
Nishat Tasnim 50
Testing effectiveness (Phase 2)UnknownNCT05927779
What this trial is testing

Study of TFX06 in Women With Advanced Breast Cancer.

Who this might be right for
ER+, HER2- Advanced Breast CancerMetastatic Breast Cancer
Zhejiang Yangli Pharmaceutical Technology Co., Ltd. 74
Not applicableStudy completedNCT01996423
What this trial is testing

Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pontificia Universidad Catolica de Chile 101
Not applicableStudy completedNCT02864966
What this trial is testing

A 24 Hour Occlusive Single Patch Test to Assess Acute Tolerance of Pre Lubricated Condom on a Panel of Healthy Adult Subjects

Who this might be right for
Healthy
Reckitt Benckiser Healthcare (UK) Limited 33
Not applicableStudy completedNCT00437216
What this trial is testing

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

Who this might be right for
Psoriasis
Galderma R&D 2,488
Not applicableStudy completedNCT03103906
What this trial is testing

Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure

Who this might be right for
Skin Care
GlaxoSmithKline 106
Next Page